Word of the members of the site

Did you set a New Years’ Resolution to feel your best in the upcoming year? Are you serious about that goal of losing weight this New Years’? Are you really able to overcome your addiction to cigarettes or alcohol? Did you or a love one just get diagnosed with a disease or illness? Are you tossing and turning all night long, leaving you exhausted at work the next morning? Well, check out our quality articles on health-related themes to help you look and feel your best!.

New Hope For Patients With Advanced Breast Cancer

Thursday, July 21, 2011

What is advanced breast cancer?

Advanced breast cancer is just a malignancy cancer. Since the early stage of the disease are usually not discovered in time to cause deterioration. The most common treatment of advanced breast cancer is the comprehensive treatment of radiotherapy and chemotherapy. There are six obvious symptoms of advanced breast cancer, they are lumps, pain, nipple discharge, breast skin changes, nipple changes, breast appearance changes.


There may be new hope for the patients that have advanced breast cancer. Researchers have found the use of trastuzumab, chemotherapy and surgery tremendously improves survival and the time central nervous system metastases is diagnosed among patients who are suffering from HER2-positive metastatic breast cancer.

About 10 % - 16 percent of women who have advanced breast cancer develop metastasis to central nervous system, which means the cancer spreads to the brain.
Within this research, 377 of the 1,023 women newly-diagnosed that have had HER2-positive breast cancer had central nervous system metastases. These patients were younger and more likely to have hormone receptor-negative disease and higher disease burden combining with those whose cancer didn't spread to the brain.

For those who diagnosed with central nervous system metastases, treatment with trastuzumab, chemo, and surgery was each connected with an improvement in survival: trastuzumab, 17.5 months vs. no trastuzumab, 3.8 months; chemotherapy, 16.4 months vs. no chemotherapy, 3.7 months; and surgery, 20.3 months vs. no surgery, 11.3 months.

"We obviously now know that these women should get trastuzumab and potentially chemotherapy, even though cancer spreads to the brain, " lead researcher Adam Brufsky, M. D. , Ph. D. , was quoted as saying. "Women with HER2-positive breast cancer have a reasonable chance of living a long time with their disease, and they should be given aggressive therapy where appropriate. "
The researchers say they are surprised that chemotherapy/trastuzumab increases the patients' survival. They had thought that that brain metastases would be dominant whatever therapy was used.
New Hope For Patients With Advanced Breast Cancer,

0 comments:

Post a Comment